Play

How does listening to patients transform cancer care? In part two of Medicine Made General’s conversation on cancer survivorship, Johns Hopkins researcher Claire Snyder, PhD, MHS, returns to explain how her work helps patients’ voices shape their care. She discusses …

Ep 5 Part 2: The Power of the Patient Voice in Cancer Care | Medicine Made General Read more »

Play

In this episode of Medicine Made General, Johns Hopkins cancer survivorship researcher Claire Snyder, PhD, MHS, joins hosts Dr. Bimal Ashar and Katie Caviness-Crolley to explore what survivorship really means—and why it begins at diagnosis, not after treatment ends. Dr. Snyder discusses how …

Ep 5 Part 1: Caring for the Whole Person: Through Cancer & Beyond | Medicine Made General Read more »

Play

AI assisted colonoscopy, where a computer helped interpret images seen during the procedure, resulted in endoscopists being less adept at recognizing precancerous lesions known as polyps, a recent study finds. Kimmel Cancer Center director William Nelson at Johns Hopkins comments. …

When you have screening colonoscopy should you worry about the endoscopist’s skills? Elizabeth Tracey reports Read more »

Play

If you’ve been treated for early breast cancer your overall risk for recurrence is small, a new large, long term study finds. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, says these risks can be pinned to …

Small risks of recurrent breast cancer may exist after treatment, Elizabeth Tracey reports Read more »

Play

Women who’ve had early breast cancer and been treated can likely lay their worries about recurrence to rest, a new study concludes. Johns Hopkins Kimmel Cancer Center director William Nelson says that’s the conclusion of this very large, long term …

Most women who’ve had early breast cancer are not at high risk for recurrence, Elizabeth Tracey reports Read more »

Play

People who’ve had colorectal cancer and have a known mutation should likely take aspirin to help prevent disease recurrence, according to a new study. The benefit of aspirin in preventing cancers has been shown before in the skin cancer melanoma, …

Aspirin may be of benefit in a number of cancers, Elizabeth Tracey reports Read more »

Play

People who’ve had colorectal cancer and who have a mutation known as  PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson:  There were …

What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports Read more »